Five-Year Prognosis of Complete Mesocolic Excision in Patients with Colon Cancer: A Prospective, Nonrandomized, Double-Blind Controlled Trial.

MLA

Wang, Chao, et al. “Five-Year Prognosis of Complete Mesocolic Excision in Patients with Colon Cancer: A Prospective, Nonrandomized, Double-Blind Controlled Trial.” Journal of the American College of Surgeons (2563-9021), vol. 235, no. 4, Oct. 2022, pp. 666–76. EBSCOhost, https://doi.org/10.1097/XCS.0000000000000282.

APA

Wang, C., Gao, Z., Shen, Z. F., Jiang, K., Zhou, J., Wang, S., & Ye, Y. (2022). Five-Year Prognosis of Complete Mesocolic Excision in Patients with Colon Cancer: A Prospective, Nonrandomized, Double-Blind Controlled Trial. Journal of the American College of Surgeons (2563-9021), 235(4), 666–676. https://doi.org/10.1097/XCS.0000000000000282

Chicago

Wang, Chao, Zhidong Gao, Zhanlong FACS Shen, Kewei Jiang, Jing Zhou, Shan Wang, and Yingjiang Ye. 2022. “Five-Year Prognosis of Complete Mesocolic Excision in Patients with Colon Cancer: A Prospective, Nonrandomized, Double-Blind Controlled Trial.” Journal of the American College of Surgeons (2563-9021) 235 (4): 666–76. doi:10.1097/XCS.0000000000000282.